Cardiomyopathy classification has been subject to revisions for >60 years. The new MOGE(S) classification system, which incorporates information on structural and functional abnormalities, organ involvement, genetics, aetiology, and disease severity, is a step towards a globally accepted nomenclature, but needs to be applicable in all health-care systems around the world.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Arbustini, E. et al. The MOGE(S) classification for a phenotype–genotype nomenclature of cardiomyopathy: endorsed by the World Heart Federation. J. Am. Coll. Cardiol. 62, 2046–2072 (2013).
Watkins, D. A. & Mayosi, B. M. The contribution of South Africans to the subject of dilated cardiomyopathy. Cardiovasc. J. Afr. 20, 11–16 (2009).
Report of the WHO/ISFC Task Force on the Definition and Classification of Cardiomyopathies. Br. Heart J. 44, 672–673 (1980).
Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 93, 841–842 (1996).
Maron, B. J. et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association scientific statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113, 1807–1816 (2006).
Mayosi, B. M. Cardiomyopathies and myocardial disorders in Africa: present status and the way forward. Cardiovasc. J. Afr. 24, 65–71 (2013).
Elliott, P. et al. Classification of the cardiomyopathies: a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur. Heart J. 29, 270–276 (2008).
Elliott, P. M. Classification of cardiomyopathies: evolution or revolution? J. Am. Coll. Cardiol. 62, 2073–2074 (2013).
Chetty, S. & Mitha, A. S. Arrhythmias in idiopathic dilated cardiomyopathy: a preliminary study. S. Afr. Med. J. 77, 190–193 (1990).
Sliwa, K. & Mayosi, B. M. Recent advances in the epidemiology, pathogenesis and prognosis of acute heart failure and cardiomyopathy in Africa. Heart 99, 1317–1322 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Mayosi, B. MOGE(S): a standardized classification of cardiomyopathies?. Nat Rev Cardiol 11, 134–135 (2014). https://doi.org/10.1038/nrcardio.2013.219
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrcardio.2013.219
This article is cited by
-
The MOGE(S) classification for cardiomyopathies: current status and future outlook
Heart Failure Reviews (2017)
-
MOGE(S) nosology in low-to-middle-income countries
Nature Reviews Cardiology (2014)